Dr. Timothy B. Niewold is a physician-scientist who has pioneered research in the underlying genetic causes of lupus, rheumatoid arthritis and other autoimmune diseases.
His dedication to identifying and understanding how autoimmune disease develops and affects the human body has awarded him many honors, including the Mary Betty Stevens Prize for Lupus Research from the Lupus Foundation of America and the Henry Kunkel Young Investigator Award from the American College of Rheumatology.
Dr. Niewold is currently the Editor-in-Chief of the Journal of Immunological Methods, serves on the Board of Directors of the Lupus Research Foundation and the Lupus Foundation of America Medical and Scientific Advisory Board, and is a standing member of the joint programmatic review panel of the U.S. Department of Defense's Peer Reviewed Medical Research Program. He has recently served as a standing member of the National Institutes of Health (NIH) Arthritis, Connective Tissue, and Skin (ACTS) Study Section. He is a former Chair of the Scientific Advisory Council of the Rheumatology Research Foundation, and a past President of the Central Society for Clinical and Translational Research.
Dr. Niewold returns to HSS from the New York University Grossman School of Medicine, where he served as Judith and Stewart Colton Professor of Medicine and Director of the Colton Center for Autoimmunity. His interests currently involve the use of personalized medicine in the treatment of autoimmune disorders.
Barbara Volcker Center for Women and Rheumatic Diseases
Lupus and APS Center of Excellence
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Director, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery
Member, American Association for the Advancement of Science
Member, American Association of Immunologists
Fellow, American College of Rheumatology
Member, American Society for Human Genetics
Past President, Central Society for Clinical Research
Past Board of Directors, Federation of Clinical Immunology Societies (FOCiS)
Member, Hench Society, Mayo Clinic Alumni Association
Member, Henry Kunkel Society
American Board of Internal Medicine
Rheumatology Subspecialty Board Certified
Henry Kunkel Young Investigator Award, American College of Rheumatology, 2018
Mary Betty Stevens Prize for Lupus Research, Lupus Foundation of America, 2015
Arthritis National Research Foundation Eng Tan Scholar Award 2009-2010
NIH CTSA K12 Scholar Award at the University of Chicago 2008-2010
Arthritis National Research Foundation Scholar 2008-2009
MD, University of Illinois, Chicago, IL, 2001
BS, University of Illinois, Champaign/Urbana, IL, 1997
Internal Medicine, Mayo Clinic, Rochester, MN, 2004
Rheumatology, Hospital for Special Surgery, New York, NY, 2007
English
Editor-in-Chief, Journal of Immunological Methods (Elsevier)
Associate Editor, Frontiers in Immunology, Molecular Innate Immunity (Frontiers)
Associate Editor, Lupus Science and Medicine (BMJ)
Associate Editor, Translational Research (Elsevier)
For all publications, please see the PubMed listing.
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
Below are the healthcare industry relationships reported by Dr. Niewold as of February 16, 2024.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
